Chinese Clinical Oncology ›› 2019, Vol. 24 ›› Issue (2): 108-112.

Previous Articles     Next Articles

Targeted regulation of MAP3K9 expression by microRNA-148a-3p and its effect on proliferation and apoptosis of gastric cancer cells

  

  1. Department of Oncology, Integrative Medicine, Cancer Hospital Affiliated to Zhengzhou University, Zhengzhou 450008, China

  • Received:2018-08-13 Revised:2018-11-22 Online:2019-02-28 Published:2019-03-18

Abstract:

Objective  To investigate the targeted regulation of mitogen-activated protein kinase 9 (MAP3K9) expression by microRNA-148a-3p (miR-148a-3p) and its effect on proliferation and apoptosis of gastric cancer cells. MethodsGastric cancer MGC-803 cells at the logarithmic growth phase were transfected with miR-148a-3p mimics (mimics group) and negative control (NC group), and the untransfected MGC-803 cells were used as control group. Real-time quantitative PCR (QPCR) was used to detect the expression of miR-148a-3p after transfection in each group to evaluate the transfection efficiency. MTT proliferation assay was conducted to evaluate the proliferation. Flow cytometry was used to detect apoptosis in each group. The expression of Bcl-2, Bax, caspase-3 and MAP3K9 were detected by QPCR and Western blotting, respectively. The targeting relationship between miR-148a-3p and MAP3K9 was verified by double luciferase report assay. Results The Results  of QPCR showed that the expression of miR-148a-3p in control group, NC group and mimics group were 1.021±0.123, 1.087±0.196 and 2.854±0.368, respectively. Compared with control group and NC group, the expression of miR-148a-3p in mimics group was higher (P<0.05). The proliferation activity of MGC-803 cells in mimics group was weaker than that in the other two groups (P<0.05). The apoptotic rate in mimics group was (15.2±1.6)%, higher than (3.5±0.9)% of control group and (4.5±1.1)% of NC group (P<0.05). Compared with other two groups, the expressions of MAP3K9 and Bcl-2 were down-regulated in the mimics group, while the expressions of Bax and caspase-3 were up-regulated significantly (P<0.05). Double luciferase assay confirmed that MAP3K9 was the direct target of miR-148a-3p. Conclusion MiR-148a-3p can inhibit the proliferation and induce apoptosis of MGC-803 cells as anti-cancer factor possibly by targeting MAP3K9. MiR-148a-3p/MAP3K9 axis has a certain application prospect in the prevention and treatment of gastric cancer.

Key words: Gastric cancer, MicroRNA-148a-3p, Mitogen-activated protein kinase 9(MAP3K9), Proliferation, Apoptosis

CLC Number: 

  • R735.2
[1] CHENG Chunlai, DING Wen, CHE Yuan.. Experimental study of YKL-40 regulating cisplatin resistance in endometrial cancer [J]. Chinese Clinical Oncology, 2019, 24(2): 113-118.
[2] YANG Caidi, WANG Lijuan, ZENG Dinghua, ZHU Jianmei..

MiR-122 induces apoptosis of glioma cells by targeting RUNX2 [J]. Chinese Clinical Oncology, 2019, 24(2): 124-128.

[3] Department of Gastroenterology, Central Hospital Affiliated to Shenyang Medical College, Shenyang , China.

Effect of mithramycin on cell cycle and apoptosis of gastric cancer cells and its possible mechanism [J]. Chinese Clinical Oncology, 2019, 24(2): 133-136.

[4] WEI Lei, LI Zixiong, QIN Shuqui, LIU Xiufeng..

The meta-analysis of clinical efficacy of gemcitabine monotherapy and gemcitabine combined with nab-paclitaxel for East Asian patients with advanced stage pancreatic adenocarcinoma [J]. Chinese Clinical Oncology, 2019, 24(2): 137-144.

[5] ZHANG Ning, LU Chuangxin, WU Sen, HE Yi, WEI Li. .

Expression and clinical significance of miRNA-138-5p in non-small cell lung cancer [J]. Chinese Clinical Oncology, 2019, 24(2): 149-152.

[6] YANG Jinsheng, GU Xuanmin, FANG Junchao..

Methylation of MGMT promoter in glioma and its clinical significance  [J]. Chinese Clinical Oncology, 2019, 24(2): 153-157.

[7] LI Zhenmiao, SONG Bo, ZHAO Yi..

Clinical observation on the long-term survival and immune function of breast-conserving surgery with X-ray intensity-modulated radiotherapy [J]. Chinese Clinical Oncology, 2019, 24(2): 158-162.

[8] LIU Zhengcao, CHEN Qingqing, YUAN Guangda, ZHU Jiahao, WU Jinchang, JI Shengjun..

Value of neutrophil/lymphocyte ratio in evaluating the prognosis of senile esophageal carcinoma after radiotherapy [J]. Chinese Clinical Oncology, 2019, 24(2): 167-170.

[9] WANG Ying, ZHANG Tongmei, DONG Yujie, LI Baolan..

Clinical analysis of 24 cases of thymic squamous cell carcinoma [J]. Chinese Clinical Oncology, 2019, 24(2): 171-174.

[10] . [J]. Chinese Clinical Oncology, 2019, 24(2): 188-189.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. Chinese Clinical Oncology, 2009, 14(4): 306 .
[2] . [J]. Chinese Clinical Oncology, 2009, 14(5): 466 .
[3] . [J]. Chinese Clinical Oncology, 2009, 14(5): 457 .
[4] . [J]. Chinese Clinical Oncology, 2009, 14(6): 505 .
[5] . [J]. Chinese Clinical Oncology, 2009, 14(7): 634 .
[6] . [J]. Chinese Clinical Oncology, 2009, 14(7): 628 .
[7] . [J]. Chinese Clinical Oncology, 2009, 14(8): 743 .
[8] . [J]. Chinese Clinical Oncology, 2009, 14(10): 912 .
[9] . [J]. Chinese Clinical Oncology, 2010, 15(5): 441 .
[10] . [J]. Chinese Clinical Oncology, 2011, 16(2): 165 .